# ORKA (Oruka Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Oruka Therapeutics, Inc. reported $1.23B in total assets and a net loss of $152.6M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ORKA
- Markdown: https://convexityos.com/fundamentals/ORKA.md
- SEC CIK: 0000907654
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000907654&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$183.1M | Operating profit |
| Net Income | FY 2025 | -$152.6M | GAAP bottom line |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -$123.9M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $920.3M | Total debt: $2.93M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $100.6M | $1.01M | $4.75M | $13.83M | $4.99M | $1.83M | $4.24M | $14.08M | $12.35M | $7.06M |
| Total Operating Expenses | $122.1M | $7.30M | $10.60M | $19.34M | $9.77M | $5.81M | $8.12M | $18.71M | $16.61M | $11.46M |
| **Operating Income** | -$122.1M | -$7.30M | -$10.60M | -$19.34M | -$9.77M | -$5.81M | -$8.12M | -$18.71M | -$16.61M | -$11.46M |
| **EBITDA** | -$122.0M | -$7.28M | -$10.58M | -$19.32M | -$9.76M | -$5.80M | -$8.10M | -$18.68M | -$16.59M | -$11.44M |
| Interest Income | $16.63M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest Expense | -- | -- | -- | -- | $9.0K | $7.0K | $8.0K | $6.0K | -- | $4.0K |
| Income Before Tax | -$105.4M | -- | -- | -$19.32M | -$9.75M | -$5.65M | -$7.96M | -$18.55M | -$16.44M | -- |
| Income Tax Expense | -- | $0 | $0 | $0 | -$9.0K | -$167K | -$31K | -$61K | $0 | $0 |
| **Net Income** | -$105.4M | -$5.34M | -$9.93M | -$19.32M | -$9.74M | -$5.48M | -$7.93M | -$18.49M | -$16.44M | -$11.45M |
| Basic EPS | -- | -$0.37 | -$0.69 | -$1.39 | -$2.07 | -$4.15 | -$10.31 | -$1.77 | -$1.81 | -$1.82 |
| **Diluted EPS** | -- | -$0.37 | -$0.69 | -$1.39 | -$2.07 | -$4.15 | -$10.31 | -$1.77 | -$1.81 | -$1.82 |
| Basic Shares Outstanding | -- | 14.4M | 14.4M | 13.9M | 4.7M | 1.3M | 769.4K | 10.4M | 9.1M | 6.3M |
| Diluted Shares Outstanding | -- | 14.4M | 14.4M | 13.9M | 4.7M | 1.3M | 769.4K | 10.4M | 9.1M | 6.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $53.70M | $43.26M | $29.14M | $27.64M | $28.99M | $24.09M | $19.93M | $25.50M |
| Total Operating Expenses | $62.14M | $50.11M | $36.43M | $34.43M | $34.10M | $28.43M | $25.09M | $30.32M |
| **Operating Income** | -$62.14M | -$50.11M | -$36.43M | -$34.43M | -$34.10M | -$28.43M | -$25.09M | -$30.32M |
| **EBITDA** | -$62.09M | -$50.06M | -$36.39M | -$34.40M | -$34.09M | -$28.41M | -$25.07M | -- |
| Interest Income | $12.17M | $8.90M | $4.61M | $4.85M | $3.83M | $3.86M | $4.09M | -- |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Net Income** | -$49.97M | -$41.21M | -$31.82M | -$29.58M | -$30.28M | -$24.57M | -$21.00M | -$25.78M |
| Basic EPS | -- | -- | -- | -- | -- | -$0.46 | -$0.40 | -- |
| **Diluted EPS** | -- | -- | -- | -- | -- | -$0.46 | -$0.40 | -- |
| Basic Shares Outstanding | -- | -- | -- | -- | -- | 42.1M | 41.7M | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | -- | 42.1M | 41.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $46.94M | $61.58M | -- | $37.43M | $42.45M | $53.36M | $49.07M | $8.36M | $6.61M | $8.70M |
| Short-Term Investments | $290.1M | $314.1M | -- | -- | -- | -- | -- | -- | -- | $3.05M |
| **Cash & Short-Term Investments** | $337.0M | $375.6M | -- | $37.43M | $42.45M | $53.36M | $49.07M | $8.36M | $6.61M | $11.75M |
| Other Current Assets | -- | -- | -- | $161K | $254K | $1.06M | $897K | $117K | $169K | $547K |
| **Total Current Assets** | $343.9M | $376.9M | $1.0K | $37.59M | $42.70M | $54.42M | $49.97M | $8.48M | $6.78M | $12.30M |
| Property, Plant & Equipment, Net | $288K | $162K | -- | $10K | $25K | $48K | $21K | $10K | $24K | $42K |
| Long-Term Investments | $142.5M | $18.07M | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $103K | $43K | -- | $12K | $18K | $18K | $12K | $24K | $24K | $24K |
| **Total Non-Current Assets** | $144.8M | $19.15M | $0 | $269K | $386K | $503K | $461K | $56K | $48K | $66K |
| **Total Assets** | $488.6M | $396.0M | $1.0K | $37.86M | $43.09M | $54.92M | $50.43M | $8.54M | $6.83M | $12.37M |
| Accounts Payable | $4.16M | $3.46M | -- | $362K | $334K | $1.12M | $1.77M | $418K | $230K | $622K |
| **Total Current Liabilities** | $15.37M | $13.04M | -- | $637K | $1.13M | $3.50M | $3.50M | $926K | $793K | $2.07M |
| **Total Non-Current Liabilities** | $1.31M | $755K | -- | $204K | $280K | $383K | $409K | $0 | $0 | $20K |
| **Total Liabilities** | $16.69M | $13.80M | $0 | $841K | $1.41M | $3.88M | $3.91M | $926K | $793K | $2.09M |
| **Total Debt (incl. Leases)** | $1.93M | $968K | -- | $280K | $383K | $483K | $450K | $25.00M | $0 | $0 |
| Common Stock | $49K | $37K | -- | $14K | $14K | $14K | $10K | $2.0K | $1.0K | $12K |
| Retained Earnings | -$189.2M | -$83.72M | -- | -$188.7M | -$183.4M | -$173.5M | -$154.2M | -$144.4M | -$138.9M | -$131.0M |
| Accumulated Other Comp. Income | $546K | -$41K | -- | -- | -- | -- | -- | -- | -- | -$2.0K |
| **Total Stockholders' Equity** | $471.9M | $382.2M | $1.0K | $37.02M | $41.67M | $51.04M | $46.52M | $7.61M | $6.03M | $10.28M |
| Total Equity | $471.9M | $382.2M | $1.0K | $37.02M | $41.67M | $51.04M | $46.52M | $7.61M | $6.03M | $10.28M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $191.5M | $268.5M | $49.52M | $46.94M | $91.25M | $65.40M | $83.57M | $61.58M |
| Short-Term Investments | $728.8M | $605.1M | $339.3M | $290.1M | $257.9M | $263.0M | $265.5M | $314.1M |
| **Cash & Short-Term Investments** | $920.3M | $873.6M | $388.8M | $337.0M | $349.2M | $328.4M | $349.1M | $375.6M |
| **Total Current Assets** | $941.5M | $884.6M | $395.2M | $343.9M | $355.2M | $332.0M | $352.1M | $376.9M |
| Property, Plant & Equipment, Net | $309K | $275K | $318K | $288K | $253K | $174K | $159K | $162K |
| Long-Term Investments | $286.3M | $252.0M | $107.1M | $142.5M | $151.8M | $23.05M | $23.95M | $18.07M |
| Other Non-Current Assets | $128K | $128K | $103K | $103K | $103K | $103K | $103K | $43K |
| **Total Non-Current Assets** | $289.5M | $254.8M | $109.2M | $144.8M | $154.1M | $25.41M | $25.03M | $19.15M |
| **Total Assets** | $1.23B | $1.14B | $504.5M | $488.6M | $509.3M | $357.4M | $377.1M | $396.0M |
| Accounts Payable | $14.38M | $7.95M | $3.66M | $4.16M | $2.21M | $4.66M | $3.54M | $3.46M |
| **Total Current Liabilities** | $31.78M | $22.97M | $16.63M | $15.37M | $20.97M | $12.11M | $11.72M | $13.04M |
| **Total Non-Current Liabilities** | $2.09M | $1.88M | $1.13M | $1.31M | $1.49M | $1.67M | $664K | $755K |
| **Total Liabilities** | $33.88M | $24.84M | $17.76M | $16.69M | $22.46M | $13.78M | $12.39M | $13.80M |
| **Total Debt (incl. Leases)** | $2.93M | $2.55M | $1.81M | $1.93M | $1.91M | $2.33M | $947K | $968K |
| Common Stock | $67K | $61K | $50K | $49K | $48K | $37K | $37K | $37K |
| Retained Earnings | -$312.1M | -$262.2M | -$221.0M | -$189.2M | -$159.6M | -$129.3M | -$104.7M | -$83.72M |
| Accumulated Other Comp. Income | -$5.04M | -$1.70M | -$480K | $546K | $185K | -$27K | -$6.0K | -$41K |
| **Total Stockholders' Equity** | $1.20B | $1.11B | $486.7M | $471.9M | $486.8M | $343.6M | $364.7M | $382.2M |
| Total Equity | $1.20B | $1.11B | $486.7M | $471.9M | $486.8M | $343.6M | $364.7M | $382.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$105.4M | -$5.34M | -$9.93M | -$19.32M | -$9.74M | -$5.48M | -$7.93M | -$18.49M | -$16.44M | -$11.45M |
| Depreciation & Amortization | $83K | $15K | $20K | $16K | $8.0K | $18K | $22K | $27K | $24K | $19K |
| Stock-Based Compensation | $24.24M | $686K | $556K | $497K | $43K | $151K | $273K | $458K | $576K | $599K |
| Change in Payables | -- | $28K | -$783K | -$411K | $1.10M | $188K | -$392K | -$583K | $841K | -$431K |
| **Operating Cash Flow** | -$88.21M | -$5.01M | -$10.91M | -$18.76M | -$7.72M | -$4.80M | -$8.24M | -$17.47M | -$14.99M | -$10.53M |
| Capital Expenditure | -$209K | $0 | -$2.0K | -$43K | -$19K | -$4.0K | -$4.0K | -$3.0K | -$12K | -$11K |
| **Free Cash Flow** | -$88.42M | -$5.01M | -$10.91M | -$18.80M | -$7.74M | -$4.80M | -$8.25M | -$17.48M | -$15.00M | -$10.54M |
| Purchases of Investments | -$521.0M | -- | -- | -- | -- | -- | -- | -$5.47M | -- | -- |
| **Investing Cash Flow** | -$96.75M | $0 | -$2.0K | -$43K | -$19K | -$4.0K | $3.05M | $12.93M | -$16.41M | -$11K |
| Common Stock Issued | $671K | -- | -- | $24.07M | $50.89M | $7.28M | $3.53M | $6.55M | -- | $37.00M |
| **Financing Cash Flow** | $170.3M | $0 | $0 | $23.09M | $48.45M | $6.56M | $3.10M | $5.85M | -- | $33.99M |
| **Net Change in Cash** | -$14.64M | -$5.01M | -$10.91M | $4.29M | $40.71M | $1.75M | -$2.09M | $1.30M | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$49.97M | -$41.21M | -$31.82M | -$29.58M | -$30.28M | -$24.57M | -$21.00M | -$25.78M |
| Depreciation & Amortization | $49K | $43K | $43K | $28K | $20K | $19K | $16K | -- |
| Stock-Based Compensation | $9.13M | $7.28M | $6.97M | $4.12M | $10.16M | $5.08M | $4.88M | $5.15M |
| **Operating Cash Flow** | -$44.33M | -$33.15M | -$23.58M | -$22.59M | -$21.60M | -$23.14M | -$20.87M | -$18.82M |
| Capital Expenditure | -$83K | $0 | -$73K | -$63K | -$99K | -$34K | -$13K | -- |
| **Free Cash Flow** | -$44.41M | -$33.15M | -$23.65M | -$22.66M | -$21.70M | -$23.18M | -$20.88M | -- |
| Purchases of Investments | -$329.5M | -$490.5M | -$90.83M | -$101.0M | -$267.7M | -$108.0M | -$44.29M | -- |
| **Investing Cash Flow** | -$159.4M | -$410.9M | -$14.44M | -$22.02M | -$122.4M | $4.86M | $42.87M | -- |
| Common Stock Issued | $4.29M | $4.37M | $1.70M | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $126.8M | $663.0M | $40.60M | -- | -- | -- | -- | -$526K |
| **Net Change in Cash** | -$76.95M | $218.9M | $2.58M | -$44.32M | $25.86M | -$18.18M | $22.00M | -$349.3M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -22.3% | -14.4% | -23.8% | -37.9% | -20.9% | -72.0% | -131.5% | -180.0% | -74.1% | -30.1% |
| Return on Assets (ROA) | -21.6% | -14.1% | -23.0% | -35.2% | -19.3% | -64.2% | -116.2% | -149.5% | -66.8% | -28.9% |
| Current Ratio | 22.37x | 59.01x | 37.72x | 15.56x | 14.28x | 9.16x | 8.55x | 5.94x | 8.95x | 25.88x |
| Quick Ratio | 21.92x | 58.76x | 37.50x | 15.25x | 14.02x | 9.03x | 8.33x | 5.68x | 8.83x | 25.80x |
| Debt to Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 3.29x | 0.00x | 0.00x | 0.00x | 0.00x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -12.7% | -11.9% | -23.9% | -22.3% | -20.9% | -29.1% | -26.8% | -21.9% |
| Return on Assets (ROA) | -12.4% | -11.7% | -23.0% | -21.6% | -20.0% | -28.0% | -25.9% | -21.1% |
| Current Ratio | 29.62x | 38.51x | 23.76x | 22.37x | 16.94x | 27.42x | 30.03x | 28.89x |
| Quick Ratio | 28.96x | 38.03x | 23.38x | 21.92x | 16.65x | 27.12x | 29.78x | 28.80x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
